Concepedia

Publication | Open Access

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

DOIFull Paper Access

1.1K

Citations

43

References

2007

Year

James J. Vredenburgh, Annick Desjardins, James E. Herndon, Jeannette M. Dowell, David A. Reardon, Jennifer A. Quinn, Jeremy N. Rich, Sith Sathornsumetee, Sridharan Gururangan, Melissa Wagner,
Clinical Cancer Research

Abstract

The combination of bevacizumab and irinotecan is an active regimen for recurrent grade III-IV glioma with acceptable toxicity.

References

YearCitations

Page 1